FLI1 and hereditary clear cell renal cell carcinoma: Therefore, in vivo toxicity profile and anti-angiogenic potential of promising benzenesulphonyl hydrazone derivative possessing antiproliferative activity, particularly against renal cell carcinoma, were assessed in our study using zebrafish models (AB and Tg(fli1: EGFP)) [18].